Taking a view at the current multiple sclerosis landscape: hype, promises and successes...
The multiple sclerosis (MS) landscape includes several assets promising a…
Is the FDA ready for artificial intelligence and machine learning?
Software as a Medical Device (SaMD) - FDA’s AI/ML Plan The greatest advantage…
Resistance is futile...or maybe not?
Amid all the news on COVID-19, it is easy to forget about one of the greatest…
A lesser-known competitive strategy involving authorized generics
Authorized generics (AGs) is a less frequently heard terminology but an…
The next frontier: prescribing a breath of fresh air!
In this world of lockdowns and working from home it is important to dedicate…
Analyzing Twitter data for deeper insights in the migraine space.
The challenge: How to find actionable insights in an information overload…
Should we trust vaccines or not?
The first COVID-19 vaccines have been administered in several countries around…
When it comes to COVID-19, a “nose job” might do the trick
Injectable COVID-19 vaccines may not be the only preventative measure against…
Virtual Sales Representatives: the new normal?
As the COVID-19 pandemic continues to disrupt daily life, businesses continue…
Is the pharmaceutical industry ready for the ‘digital’ generations?
Digital health technologies are transforming the entire patient journey — from…
Enhancing participant diversity in clinical trials
Clinical trials are carefully designed research studies that evaluate the…